Related by context. Frequent words. (Click for all words.) 67 http:/www.clinicaltrials.gov 65 www.clinicaltrials.gov 64 Initiates Phase II 62 www.incyte.com 61 Phase Ib IIa 61 R sorafenib tablets 61 signal detection CTSD 60 Completes Patient Enrollment 59 Randomized controlled 58 Buffalo Bills Insider 58 Allovectin 7 ® 57 interferon gamma 1b 57 sorafenib tablets 57 Romidepsin 57 trastuzumab DM1 T DM1 57 Presents Positive 57 refractory chronic lymphocytic 57 Phase Ib II 57 ASSERT 57 GVAX R 57 Pivotal Phase III 57 Panzem R NCD 57 XL# XL# XL# XL# 56 oncolytic virus therapies 56 recurrent glioblastoma multiforme 56 Entereg R 56 Italy coul 56 forodesine 56 SYMMETRY trial 56 thetreatment 56 phase IIb clinical 56 please visit www.rosettagenomics.com 56 Initiate Phase 56 Genasense ® oblimersen 56 Panzem R 56 commercial bioproduction 56 castrate resistant prostate cancer 56 Belimumab 55 optical biosensors 55 correlate genetic variation 55 Trofex 55 Regulatory Disclosure 55 ZFP Therapeutics 55 tramiprosate ALZHEMED TM 55 Meets Primary Endpoint 55 Diamyd R 55 CMV vaccine 55 Allovectin 7 R 55 LibiGel Phase III 55 Xanafide 55 Darinaparsin 55 Sapacitabine 55 neratinib 55 HORIZONS AMI 55 By RICK KRETZSCHMAR 55 mso pagination widow 54 BioNumerik 54 metastatic colorectal 54 Daclizumab 54 Free apologetics 54 Patient Registries 54 Genasense ® 54 BCIRG 54 % #F# 4v.jsn 54 systemically administered 54 KRN# 54 Prestara 54 phase IIa clinical 54 SAR# [004] 54 PittsburgMo 54 BiTE R 54 Completes Enrollment 54 CALGB 54 prospectively defined 54 Alzhemed TM 54 huC# DM4 54 ongoing Phase 1b 54 MADIT II 54 lung pancreatic 54 N Engl J 54 advanced carcinoid 54 metastatic castration resistant 54 Mark A. Sirgo 53 Randomised 53 invasive lobular carcinoma 53 Reader Comment Guidelines 53 Genasense R oblimersen 53 Omacetaxine 53 MKC# 53 pharmacokinetic pharmacodynamic 53 BARI 2D 53 Pirfenidone 53 IMC #B 53 LUX Lung 53 senicapoc 53 BY MARK WILSON 53 Fibrillex TM 53 dose escalation clinical 53 UVIDEM 53 By CHARLES WARD 53 Accessed #/#/# [001]